BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burckhardt RM, Dennehy JJ, Poon LLM, Saif LJ, Enquist LW. Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters. J Virol 2021;:JVI0197321. [PMID: 34817198 DOI: 10.1128/JVI.01973-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Cvetkovic-vega A, Urrunaga-pastor D, Soto-becerra P, Figueroa Morales LE, Fernández-bolivar L, Alvizuri-pastor S, Oyanguren-miranda M, Vera IMN, Carrillo Ramos EE, Sagástegui AA, Contreras Macazana RM, Rengifo DEL, Castro NG, Apolaya-segura M, Maguina JL. Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm). Travel Medicine and Infectious Disease 2022. [DOI: 10.1016/j.tmaid.2022.102514] [Reference Citation Analysis]
2 Maltezou HC, Gamaletsou MN, Koukou D, Giannouchos TV, Sourri F, Syrimi N, Karapanou A, Lemonakis N, Peskelidou E, Papanastasiou K, Panagopoulos P, Souliotis K, Lourida A, Hatzigeorgiou D, Sipsas NV. Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.10.049] [Reference Citation Analysis]
3 Shaik RA, Ahmad MS, Alzahrani M, Alzerwi NAN, Alnemare AK, Reyzah M, Albar HM, Alshagrawi S, Elkhalifa AME, Alzahrani R, Alrohaimi Y, Mahfoz TMB, Ahmad RK, Alahmdi RA, Al-baradie NRS. Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine. Vaccines 2022;10:1689. [DOI: 10.3390/vaccines10101689] [Reference Citation Analysis]
4 Sitompul PA, Mariana N, Budiman E, Tanjung DW, Ariesanty B, Hartono TS, Jahiroh J, Ernita C, Dinar A, Puspitasari A, Herlina H, Suliati S, Murtiani F, Maemun S, Syahril M. Quantitative Antibody Levels in Hospital Workers after Receiving three Doses of CoviD-19 vaccines. Biomed Pharmacol J 2022;15:1745-1749. [DOI: 10.13005/bpj/2513] [Reference Citation Analysis]
5 Lin Y, Huang Z, Xu X, Du W, Alias H, Hu Z, Wong LP. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China. Hum Vaccin Immunother 2022;:2126667. [PMID: 36165498 DOI: 10.1080/21645515.2022.2126667] [Reference Citation Analysis]
6 Deng J, Ma Y, Liu Q, Du M, Liu M, Liu J. Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. IJERPH 2022;19:10752. [DOI: 10.3390/ijerph191710752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Qin W, Zhang X, Wang Y, Pan F, Cheng K, Huang F, Song J, Su H. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China. Front Public Health 2022;10:943876. [DOI: 10.3389/fpubh.2022.943876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Williams M, Haider N, Mangat J, Hosein Z, Balendra V, Abbasi AF, Desai P, Jain I, Utulor S, Abioye A. Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 2022;10:251513552210975. [DOI: 10.1177/25151355221097559] [Reference Citation Analysis]
9 Dhawan M, Emran TB, Choudhary OP. Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2. Annals of Medicine and Surgery 2022;77:103612. [DOI: 10.1016/j.amsu.2022.103612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Attia S, Mausbach K, Klugar M, Howaldt H, Riad A. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees. Front Public Health 2022;10:846861. [DOI: 10.3389/fpubh.2022.846861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Siller A, Seekircher L, Wachter GA, Astl M, Tschiderer L, Pfeifer B, Gaber M, Schennach H, Willeit P. Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021. Viruses 2022;14:568. [DOI: 10.3390/v14030568] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
12 Siller A, Seekircher L, Wachter GA, Astl M, Tschiderer L, Pfeifer B, Gaber M, Schennach H, Willeit P. Seroprevalence, waning, and correlates of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Large-scale study of 35,193 blood donors conducted between June 2020 and September 2021.. [DOI: 10.1101/2021.12.27.21268456] [Reference Citation Analysis]